LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT – Vertex Pharmaceuticals Incorporated Transaction History
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT portfolio value:
$4.56M
portfolio value
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.67% | -2.5K shares | -584K | $289.54 | 15.78K |
| Q2 2022 | share | Decrease | -3.18% | -600 shares | 224K | $281.79 | 18.28K |
| Q1 2022 | share | Increase | +22.75% | 3.5K shares | 1.55M | $260.97 | 18.88K |
| Q4 2021 | share | Decrease | -8.88% | -1.5K shares | 316K | $222.45 | 15.38K |
| Q3 2021 | share | Decrease | -2.31% | -400 shares | -422K | $181.39 | 16.88K |
| Q2 2021 | share | Increase | +6.80% | 1.1K shares | 7K | $201.63 | 17.28K |
| Q1 2021 | share | Increase | +13.30% | 1.9K shares | 101K | $214.89 | 16.18K |
| Q4 2020 | share | Increase | +26.58% | 3K shares | 305K | $236.34 | 14.28K |
| Q3 2020 | share | Increase | +23.80% | 2.17K shares | 426K | $272.12 | 11.28K |
| Q2 2020 | share | 0.00% | 0 shares | 477K | $290.31 | 9.11K | |
| Q1 2020 | share | Increase | +10.95% | 900 shares | 370K | $237.95 | 9.11K |
| Q4 2019 | share | Decrease | -9.87% | -900 shares | 254K | $218.95 | 8.21K |
| Q3 2019 | share | 0.00% | 0 shares | -127K | $169.42 | 9.11K | |
| Q2 2019 | share | Increase | +3.40% | 300 shares | 50K | $183.38 | 9.11K |
| Q1 2019 | share | Increase | +288.93% | 6.55K shares | 1.24M | $183.95 | 8.81K |
| Q4 2018 | share | 0.00% | 0 shares | -61K | $165.71 | 2.26K | |
| Q3 2018 | share | Decrease | -50.36% | -2.3K shares | -339K | $192.74 | 2.26K |
| Q2 2018 | share | Increase | +18.10% | 700 shares | 146K | $169.96 | 4.56K |
| Q1 2018 | share | 0.00% | 0 shares | 50K | $162.98 | 3.86K | |
| Q4 2017 | share | Decrease | -18.88% | -900 shares | -145K | $149.86 | 3.86K |
| Q3 2017 | share | 0.00% | 0 shares | 111K | $152.04 | 4.76K | |
| Q2 2017 | share | 0.00% | 0 shares | 93K | $128.87 | 4.76K | |
| Q1 2017 | share | Decrease | -61.76% | -7.7K shares | -397K | $109.35 | 4.76K |
| Q4 2016 | share | Decrease | -41.38% | -8.8K shares | -937K | $73.67 | 12.46K |
| Q3 2016 | share | 0.00% | 0 shares | 26K | $87.21 | 21.26K | |
| Q2 2016 | share | 0.00% | 0 shares | 138K | $86.02 | 21.26K | |
| Q1 2016 | share | 0.00% | 0 shares | -985K | $79.49 | 21.26K |